International Symposium
The Future of Solid Organ Transplantation
Friday, June 21, 2024
9:30 AM – 1:30 PM
JW Marriott Essex House New York
160 Central Park South
New York, NY 10019
Speakers
Tolerance
Dr. Ephraim Fuchs: Keynote Speaker and Professor of Oncology and Immunology at Johns Hopkins University. Dr. Fuchs is a world-renowned bone marrow transplant physician and researcher. He is the co-developer of the danger model of immunity, which has profound implications for the understanding of the processes of transplantation tolerance versus graft rejection in humans.
- Synthetic sibling concept: What is it and why is it important?
- Update on the synthetic sibling clinical trial
Dr. Robert Montgomery: Chair, NYU Department of Surgery and Director, NYU Langone Transplant Institute
- Why Is tolerance important?
- Tolerance: Overview of the current state-of-the-art
- What the future holds for tolerance (20-year horizon)
Dr. Joseph Leventhal: Surgical Director of the Kidney Transplant Program at Northwestern University and a pioneer in the development of cell-based therapies to achieve tolerance induction in solid organ transplant recipients.
- Longitudinal study results of Phase 2 and Phase 3 tolerance patients
- Once patients are off immunosuppressive drugs, they are able to remain off them permanently
Dr. Raja Kandaswamy: Surgical Director, Kidney Transplant Program, University of Minnesota and a world leader in engineered transplant matching
- How to engineer genetic matches to maximize tolerance success
- Stem cell transplant matching is different from eplet matching
Living Donor Transplant
Dr. Amanda Leonberg-Yoo: Medical Director, Living Kidney Donor Program, University of Pennsylvania Health System
- Pathway for U.S. to double living donor transplants by leveraging microsites
- Penn case study: 500+ active microsites and 200+ qualified donor referrals in 2023
- Innovative new liver microsite pilot launched
Dr. Dorry Segev: Director, Center for Surgical and Transplant Applied Research (C-STAR), NYU Langone Health
- Why eplet matching matters
- Kidney for Life program results
- The impact of DSA on the tolerance protocol